你即將離開本站

並前往https://www.ajmc.com/view/phase-ii-study-suggest-belimumab-after-rituximab-leads-to-improvement-in-sle

Phase 2 Study Suggests Belimumab After Rituximab Leads to ...

Rituximab, a chimeric anti-CD20 monoclonal antibody, depletes B cells by targeting the CD20 antigen. Yet, the drug's performance in clinical ...

確定！ 回上一頁

查詢 「Rituximab」的人也找了：

  1. rituximab標靶
    2.
  2. rituximab中文
    3.
  3. rituximab莫須瘤
    4.
  4. Rituximab
    5.
  5. MabThera rituximab
    6.
  6. mabthera標靶
    7.
  7. rituximab副作用
    8.
  8. rituximab價格
    9.